BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38177460)

  • 1. Breast Cancer Screening and BI-RADS Scoring Trends Before and During the COVID-19 Pandemic in an Academic Safety-Net Hospital.
    Kobzeva-Herzog A; O'Shea T; Young S; Kenzik K; Zhao X; Slanetz P; Phillips J; Merrill A; Cassidy MR
    Ann Surg Oncol; 2024 Apr; 31(4):2253-2260. PubMed ID: 38177460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study.
    Kerlikowske K; Scott CG; Mahmoudzadeh AP; Ma L; Winham S; Jensen MR; Wu FF; Malkov S; Pankratz VS; Cummings SR; Shepherd JA; Brandt KR; Miglioretti DL; Vachon CM
    Ann Intern Med; 2018 Jun; 168(11):757-765. PubMed ID: 29710124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of unconventional utilization of BI-RADS category 3 assessment at opportunistic screening.
    Altas H; Tureli D; Cengic I; Kucukkaya F; Aribal E; Kaya H
    Acta Radiol; 2016 Nov; 57(11):1304-1309. PubMed ID: 26019241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the results of mammography screening in Dubrovnik-Neretva County in the 2006-2009 period].
    Dzono-Boban A; Mratović MC; Masanović M
    Acta Med Croatica; 2010 Dec; 64(5):453-9. PubMed ID: 21692270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis for the breast cancer screening among urban populations in China, 2012-2013].
    Mi ZH; Ren JS; Zhang HZ; Li J; Wang Y; Fang Y; Shi JF; Zhang K; Zhao JB; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Oct; 50(10):887-892. PubMed ID: 27686767
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.
    Berg WA; Berg JM; Sickles EA; Burnside ES; Zuley ML; Rosenberg RD; Lee CS
    Radiology; 2020 Jul; 296(1):32-41. PubMed ID: 32427557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why Start Now? Retrospective Study Evaluating Baseline Screening Mammography in Patients Age 60 and Older.
    Chieh AY; Willis JG; Carroll CM; Mobley AA; Li Y; Li M; Woodard S
    Curr Probl Diagn Radiol; 2024; 53(1):62-67. PubMed ID: 37704485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of screening mammography in women less than 40 prior to fertility treatment: a retrospective pilot study.
    Greenwood HI; Greenwood EA; Lee AY; Price ER
    Clin Imaging; 2020 Feb; 59(2):109-113. PubMed ID: 31812882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
    Yao MM; Joe BN; Sickles EA; Lee CS
    Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic.
    Dontchos BN; Achibiri J; Mercaldo SF; Wang GX; Lamb LR; Miles RC; Narayan AK; Lehman CD
    AJR Am J Roentgenol; 2022 Feb; 218(2):270-278. PubMed ID: 34494449
    [No Abstract]   [Full Text] [Related]  

  • 11. Women with abnormal screening mammography lost to follow-up: An experience from Taiwan.
    Kuo CS; Chen GR; Hung SH; Liu YL; Huang KC; Cheng SY
    Medicine (Baltimore); 2016 Jun; 95(24):e3889. PubMed ID: 27310983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cross-Sectional Observational Study to Compare the Role of Ultrasound with Mammography in Women Identified at High Risk for Breast Cancer in a Population in China.
    An P; Zhong S; Zhang R; Hou X; Xi R; Wang Y
    Med Sci Monit; 2020 Jun; 26():e919777. PubMed ID: 32576809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast ultrasound diagnostic performance and outcomes for mass lesions using Breast Imaging Reporting and Data System category 0 mammogram.
    Zanello PA; Robim AF; Oliveira TM; Elias Junior J; Andrade JM; Monteiro CR; Sarmento Filho JM; Carrara HH; Muglia VF
    Clinics (Sao Paulo); 2011; 66(3):443-8. PubMed ID: 21552670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Predictive Value of BI-RADS 3, 4, and 5 Lesions Detected on Breast MRI: Correlation with Study Indication.
    Chikarmane SA; Tai R; Meyer JE; Giess CS
    Acad Radiol; 2017 Apr; 24(4):435-441. PubMed ID: 27955878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tomosynthesis in the Diagnostic Setting: Changing Rates of BI-RADS Final Assessment over Time.
    Raghu M; Durand MA; Andrejeva L; Goehler A; Michalski MH; Geisel JL; Hooley RJ; Horvath LJ; Butler R; Forman HP; Philpotts LE
    Radiology; 2016 Oct; 281(1):54-61. PubMed ID: 27139264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Negative Impact of the New Coronavirus Pandemic on the Trend of Breast Biopsies and Their Direct Costs: Interrupted Time Series Analysis.
    Hyeda A; da Costa ÉSM; Kowalski SC
    Value Health Reg Issues; 2023 May; 35():8-12. PubMed ID: 36796115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Clinical and Imaging Risk Factors in Predicting Breast Cancer Diagnosis Among BI-RADS 4 Cases.
    Hsu W; Zhou X; Petruse A; Chau N; Lee-Felker S; Hoyt A; Wenger N; Elashoff D; Naeim A
    Clin Breast Cancer; 2019 Feb; 19(1):e142-e151. PubMed ID: 30366654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the American College of Radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms.
    Lehman C; Holt S; Peacock S; White E; Urban N
    AJR Am J Roentgenol; 2002 Jul; 179(1):15-20. PubMed ID: 12076896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: a case-control study.
    Winkel RR; von Euler-Chelpin M; Nielsen M; Petersen K; Lillholm M; Nielsen MB; Lynge E; Uldall WY; Vejborg I
    BMC Cancer; 2016 Jul; 16():414. PubMed ID: 27387546
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.